ReviewCancer genomics & proteomics

Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.

Nikolaos Garmpis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.